|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4985 | |
| A61K 31/55 | |||
| C07D 471/04 | |||
| C07D 471/14 | |||
| C07D 491/14 | |||
| A61P 31/18 | |||
| A61K 45/06 |
| (11) | Number of the document | 2986291 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14785780.9 |
| Date of filing the European patent application | 2014-04-11 | |
| (97) | Date of publication of the European application | 2016-02-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/033720 |
| Date | 2014-04-11 |
| (87) | Number | WO 2014/172188 |
| Date | 2014-10-23 |
| (30) | Number | Date | Country code |
| 201361812489 P | 2013-04-16 | US |
| (72) |
GRAHAM, Thomas, H., US
WAI, John, S., US
STAMFORD, Andrew, US
LIU, Wensheng, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | 4-PYRIDONE DERIVATIVE COMPOUNDS AND USES THEREOF AS HIV INTEGRASE INHIBITORS |
| 4-PYRIDONE DERIVATIVE COMPOUNDS AND USES THEREOF AS HIV INTEGRASE INHIBITORS |